Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.

Abstract

152 patients with thromboangiitis obliterans (Buerger's disease) and pain from critical leg ischaemia were randomly allocated to receive iloprost, a chemically stable prostacyclin analogue, or low-dose aspirin, for 28 days in a double-blind trial. On review, 19 patients did not fulfil the stringent entry criteria. Of the other 133 patients, 98 also had leg ulcers. After 21-28 days, 58 (85%) of 68 iloprost-treated patients showed ulcer healing or relief of ischaemic pain, compared with 11 (17%) of 65 in the aspirin-treated group. 43 (63%) on iloprost treatment had complete relief of pain, compared with 18 (28%) on aspirin. Ulcers healed completely in 18 of 52 (35%) who received iloprost compared with 6 of 46 (13%) who received aspirin. 6 months after the start of treatment, the response rate was 45 of 51 (88%) patients treated with iloprost compared with 12 of 44 (21%) patients treated with aspirin.

• Authors: J N Fiessinger, M Schäfer
• Journal: Lancet (London, England) (Lancet) Vol. 335 Issue 8689 Pg. 555-7 (Mar 10 1990) ISSN: 0140-6736 [Print] England
• PMID: 1689791 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)

Chemical References

• Anti-Arrhythmia Agents
• Epoprostenol
• Iloprost
• Aspirin

Topics

• Adolescent
• Adult
• Amputation, Surgical
• Anti-Arrhythmia Agents (administration & dosage, adverse effects, therapeutic use)
• Arm (blood supply)
• Aspirin (administration & dosage, adverse effects, therapeutic use)
• Double-Blind Method
• Drug Administration Schedule
• Drug Evaluation
• Epoprostenol (administration & dosage, adverse effects, therapeutic use)
• Follow-Up Studies
• Humans
• Iloprost
• Ischemia (drug therapy, etiology)
• Leg (blood supply, surgery)
• Middle Aged
• Multicenter Studies as Topic
• Randomized Controlled Trials as Topic
• Thromboangiitis Obliterans (complications, surgery)